Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer

<div>The established nomogram model for predicting 48-, 96-, and 144-month OS in NSCLC stage IB patients after surgical resection. OS: overall survival and NSCLC: non-small-cell lung cancer.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer 